The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol


Received: 1 August 2015 Accepted: 29 September 2015 c © 2017 The Author(s), licensee Magdi Yacoub Institute. This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY-4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. This article… (More)
DOI: 10.21542/gcsp.2017.2


13 Figures and Tables